Aspire Biopharma | 0.3302 -0.0064 -1.90% | ||
| ASBP | |||
| 高 0.3596 | 开 0.3350 | 量 229.63万股 | 总市值 1635.35万 |
| 低 0.3240 | 换 4.64% | 额 77.26万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Aspire Biopharma(ASBP)
09-30 18:15
$Aspire Biopharma(ASBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003148 Act: 33 Size: 1 KB 网页链接
Aspire Biopharma(ASBP)
09-27 05:15
$Aspire Biopharma(ASBP)$ 8-K Current report, items 3.02, 4.01, and 9.01 Accession Number: 0001493152-25-015773 Act: 34 Size: 264 KB 网页链接
Aspire Biopharma(ASBP)
09-27 05:15
$Aspire Biopharma(ASBP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-015778 Act: 33 Size: 11 MB 网页链接
Aspire Biopharma(ASBP)
09-23 18:05
$Aspire Biopharma(ASBP)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-25-014523 Act: 34 Size: 216 KB 网页链接
Aspire Biopharma(ASBP)
09-19 05:05
$Aspire Biopharma(ASBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-25-014085 Act: 33 Size: 11 MB 网页链接
Aspire Biopharma(ASBP)
09-09 05:15
$Aspire Biopharma(ASBP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001641172-25-026871 Act: 34 Size: 219 KB 网页链接
Aspire Biopharma(ASBP)
08-23 05:25
$Aspire Biopharma(ASBP)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001641172-25-025257 Act: 34 Size: 887 KB 网页链接
Aspire Biopharma(ASBP)
08-14 05:05
$Aspire Biopharma(ASBP)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-023566 Act: 34 Size: 4 MB 网页链接
Aspire Biopharma(ASBP)
08-14 05:05
$Aspire Biopharma(ASBP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-023573 Act: 34 Size: 4 MB 网页链接
Aspire Biopharma(ASBP)
07-31 05:35
$Aspire Biopharma(ASBP)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001641172-25-021595 Act: 34 Size: 262 KB 网页链接
Aspire Biopharma(ASBP)
06-19 05:35
$Aspire Biopharma(ASBP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-015653 Act: 34 Size: 255 KB 网页链接
Aspire Biopharma(ASBP)
06-11 05:35
$Aspire Biopharma(ASBP)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-014569 Size: 6 KB 网页链接
Aspire Biopharma(ASBP)
06-10 20:35
$Aspire Biopharma(ASBP)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001641172-25-014445 Act: 34 Size: 320 KB 网页链接
Aspire Biopharma(ASBP)
06-07 05:05
$Aspire Biopharma(ASBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-014102 Size: 6 KB 网页链接
Aspire Biopharma(ASBP)
05-30 18:05
$Aspire Biopharma(ASBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-001770 Act: 33 Size: 1 KB 网页链接
Aspire Biopharma(ASBP)
05-20 08:35
$Aspire Biopharma(ASBP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001641172-25-011555 Act: 34 Size: 6 KB 网页链接
Aspire Biopharma(ASBP)
05-16 00:25
$Aspire Biopharma(ASBP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-072232 Act: 34 Size: 33 KB 网页链接
Aspire Biopharma(ASBP)
05-15 04:55
$Aspire Biopharma(ASBP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-010316 Act: 34 Size: 4 MB 网页链接
Aspire Biopharma(ASBP)
05-14 05:25
$Aspire Biopharma(ASBP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001641172-25-010013 Act: 33 Size: 8 MB 网页链接
Aspire Biopharma(ASBP)
05-08 05:25
$Aspire Biopharma(ASBP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001641172-25-009072 Act: 34 Size: 6 KB 网页链接